2-{4-[2-(2,4-Diamino-pyrido[2,3-d]pyrimidin-6-yl)-ethyl]-benzoylamino}-pentanedioic acid

ID: ALA124631

PubChem CID: 13912572

Max Phase: Preclinical

Molecular Formula: C21H22N6O5

Molecular Weight: 438.44

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1nc(N)c2cc(CCc3ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc3)cnc2n1

Standard InChI:  InChI=1S/C21H22N6O5/c22-17-14-9-12(10-24-18(14)27-21(23)26-17)2-1-11-3-5-13(6-4-11)19(30)25-15(20(31)32)7-8-16(28)29/h3-6,9-10,15H,1-2,7-8H2,(H,25,30)(H,28,29)(H,31,32)(H4,22,23,24,26,27)

Standard InChI Key:  RGUQKUKRLMXLCM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
    1.9042   -0.5917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6250   -1.8292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3375   -1.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3375   -0.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6250   -0.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9042   -1.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1792   -3.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0500   -1.8292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8917   -4.3042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1667   -5.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8917   -5.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1875   -3.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0500   -0.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0292   -5.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4667   -4.3000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4625   -5.1250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7417   -5.1500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6250    0.6458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1875   -1.8417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6000   -5.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9042   -2.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4750   -2.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7667   -1.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7667   -0.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3167   -5.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1667   -6.3667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1917   -1.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0250   -6.3792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4792   -1.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9125   -1.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4875   -0.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2000   -0.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  6  2  0
  3  2  1  0
  4  5  1  0
  5  1  2  0
  6  1  1  0
  7 12  1  0
  8  3  1  0
  9  7  1  0
 10 11  1  0
 11  9  1  0
 12 21  1  0
 13  4  1  0
 14 25  1  0
 15  7  2  0
 16 10  2  0
 17 14  2  0
 18  5  1  0
 19  6  1  0
 20 11  1  0
 21 30  2  0
 22 29  1  0
 23  8  2  0
 24 13  2  0
 25 20  1  0
 26 10  1  0
 27 32  1  0
 28 14  1  0
 29 27  2  0
 30 27  1  0
 31 24  1  0
 32 31  1  0
  4  3  2  0
 23 24  1  0
 22 12  2  0
M  END

Associated Targets(non-human)

folA Dihydrofolate reductase (640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
thyA Thymidylate synthase (501 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fpgs Folylpoly-gamma-glutamate synthetase (93 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 438.44Molecular Weight (Monoisotopic): 438.1652AlogP: 1.02#Rotatable Bonds: 9
Polar Surface Area: 194.41Molecular Species: ACIDHBA: 8HBD: 5
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 7#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.57CX Basic pKa: 3.44CX LogP: 1.02CX LogD: -5.08
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.32Np Likeness Score: -0.19

References

1. Piper JR, DeGraw JI, Colwell WT, Johnson CA, Smith RL, Waud WR, Sirotnak FM..  (1997)  Analogues of methotrexate in rheumatoid arthritis. 2. Effects of 5-deazaaminopterin, 5,10-dideazaaminopterin, and analogues on type II collagen-induced arthritis in mice.,  40  (3): [PMID:9022805] [10.1021/jm950553y]
2. Taylor EC, Harrington PJ, Fletcher SR, Beardsley GP, Moran RG..  (1985)  Synthesis of the antileukemic agents 5,10-dideazaaminopterin and 5,10-dideaza-5,6,7,8-tetrahydroaminopterin.,  28  (7): [PMID:4009615] [10.1021/jm00145a012]

Source